Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021

SELL
$24.31 - $33.6 $145,860 - $201,600
-6,000 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$26.09 - $40.4 $135,668 - $210,080
-5,200 Reduced 46.43%
6,000 $202,000
Q1 2021

Apr 27, 2021

BUY
$33.06 - $56.93 $128,934 - $222,027
3,900 Added 53.42%
11,200 $428,000
Q4 2020

Jan 20, 2021

BUY
$39.09 - $57.4 $285,357 - $419,020
7,300 New
7,300 $305,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Boyd Watterson Asset Management LLC Portfolio

Follow Boyd Watterson Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.